Yi CAO
About Yi CAO
Yi Cao is a Laboratory Supervisor at Pillar Biosciences Incorporated, specializing in cancer genomics, liquid biopsy, and single cell immune profiling. With extensive experience in clinical laboratory management and a strong educational background in medicine and business, Cao has contributed to advancements in molecular diagnostics since 2021.
Work at Pillar
Yi Cao has been serving as the Laboratory Supervisor at Pillar Biosciences Incorporated since 2021. In this role, he focuses on cancer genomics, liquid biopsy, and single cell immune profiling. His responsibilities include overseeing laboratory operations and ensuring compliance with industry standards. Pillar Biosciences is located in Natick, MA, where Yi has contributed to advancements in molecular diagnostics.
Previous Experience
Before joining Pillar Biosciences, Yi Cao worked at Massachusetts General Hospital as a Senior Medical Technologist from 2008 to 2019. He also held the position of Laboratory Operations Manager at Genuity Science for one year, from 2019 to 2020. Additionally, he served as a Research Fellow at Massachusetts General Hospital from 2005 to 2008. His extensive experience in clinical laboratory management has equipped him with a strong foundation in the field.
Education and Expertise
Yi Cao holds a Bachelor of Medicine from the Medical School of Soochow University and a Master of Science in Pharmacology from the same institution. He also earned an MBA in Business Administration from Babson F.W. Olin Graduate School of Business. His educational background supports his expertise in setting up clinical laboratories and providing NGS-based molecular diagnostic tests in compliance with CLIA and FDA regulations.
Specialization in Cancer Genomics
In his current role, Yi Cao specializes in cancer genomics, focusing on innovative techniques such as liquid biopsy and single cell immune profiling. His work emphasizes the importance of Next Generation Sequencing (NGS) in molecular diagnostics, reflecting his commitment to advancing cancer research and patient care through laboratory management.